Chimerix

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Vir

This clinical-stage biopharmaceutical company develops medicines for serious infectious diseases and cancer for global patients.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Pharmasset

This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.

Coherus

This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.